세계의 제조 공정에서 중국의 지위(2023년) : 중국의 새로운 지위와 기존 지역의 제조능력 및 생산량 비교(제2판)

An Invaluable Resource for Trends & Analysis

An in-depth review of emerging trends and opportunities, with comparative, aggregated data from BioPlan's 20^th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, providing trend information and relevant new in-depth insights into the rapidly growing and changing Chinese biologics industry.

SPECIAL SEGMENTS: Industry Reviewers' Comments in Analysis and Implications Sections.

This Report compares biomanufacturing industry insights in China with the rest of the world, and allows us to provide an insight into historical trends while keeping an eye on the outlook of the industry overall.

• Reviewed by Industry Experts
• Subject Matter Expert analysis
• 66 Pages
• 14 Segments covered
• Key Graphs and Tables

COVERAGE:

• Key Biomanufacturing Trend of 2023

• Average Cost for Primary Recombinant Protein

• Titer Ranges for mAbs at Various Production Scales

• Current Percent of Total Capacity for Facility Operation

• Capacity Constraints Today

• Downstream Bioprocessing Steps Creating Overall Capacity Constraints

• Important Areas to Avoid Significant Capacity Constraints

• Budget and Funding Percentage Changes over the Next 12 Months

• Actions to Reduce Overall Bioprocessing Costs During Past 12 Months

• Single-use/Disposable Biomanufacturing Systems

• Change in Spending on Outsourcing for Manufacturing Next 12 Months

• And More!